RareCyte delivers Precision Biology products and services for circulating tumor cell and multiplex tissue analysis designed to accelerate your cancer research.

As the leading provider, RareCyte leverages a world-class assay design team and end-to-end platform with biomarker-enabling technology to provide CTC assays that are rigorously validated for accuracy and reproducibility. RareCyte is the only full-service provider delivering custom assay development services, long-term biobanking of patient samples, CLIA-validated CTC enumeration, multi-biomarker analysis, and single cell retrieval for DNA sequencing. RareCyte additionally offers development of custom multiplex tissue panels and micro-region retrieval services for RNA-seq experiments that enable discovery science.

RareCyte products for comprehensive CTC analysis include AccuCyte Sample Preparation System, RarePlex Staining Kits, and CyteFinder Instruments, all of which are easily be deployed in research labs worldwide. RareCyte currently supports a wide range of global clinical trials with deep expertise, personalized service, and short turn-around times.